We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$17B
AUM Growth
+$1.34B
(+8.6%)
Cap. Flow
-$377M
Cap. Flow
% of AUM
-2.22%
Top 10 Holdings %
Top 10 Hldgs %
15.59%
Holding
389
New
43
Increased
82
Reduced
143
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$204M |
| 2 |
AbbVie
ABBV
|
+$141M |
| 3 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$130M |
| 4 |
Caterpillar
CAT
|
+$125M |
| 5 |
Johnson Controls International
JCI
|
+$90.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VPHM
VIROPHARMA INC
VPHM
|
+$188M |
| 2 |
Merck
MRK
|
+$155M |
| 3 |
Apple
AAPL
|
+$155M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$131M |
| 5 |
Bread Financial
BFH
|
+$96.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.01% |
| 2 | Industrials | 15.63% |
| 3 | Consumer Discretionary | 14.7% |
| 4 | Technology | 8.94% |
| 5 | Communication Services | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Home Depot
HD
$331B
| $161M | 0.95% |
1,957,629
-20,764
| -1% | -$1.62M |
|
27
Alkermes
ALKS
$8.22B
| $159M | 0.94% |
3,922,548
+393,748
| +11% | +$14.5M |
|
28
Comcast
CMCSA
$85B
| $159M | 0.94% |
6,114,830
-108,034
| -2% | -$2.6M |
|
29
Danaher
DHR
$137B
| $158M | 0.93% |
3,049,130
-34,579
| -1% | -$1.7M |
|
30
Qualcomm
QCOM
$155B
| $156M | 0.92% |
2,105,246
+222,576
| +12% | +$15.7M |
|
31
FMC
FMC
$1.34B
| $156M | 0.92% |
2,383,671
+371,837
| +18% | +$23.6M |
|
|
PCP
32
DELISTED
PRECISION CASTPARTS CORP
PCP
| $154M | 0.91% |
572,376
-10,662
| -2% | -$2.68M |
|
|
33
AbbVie
ABBV
$443B
| $153M | 0.9% |
2,891,502
+2,858,762
| +8,732% | +$141M |
|
|
NLSN
34
DELISTED
Nielsen Holdings plc
NLSN
| $149M | 0.88% |
3,255,247
-67,991
| -2% | -$2.78M |
|
|
MON
35
DELISTED
Monsanto Co
MON
| $149M | 0.88% |
1,280,190
-10,104
| -0.8% | -$1.1M |
|
36
Starbucks
SBUX
$120B
| $144M | 0.85% |
3,683,610
-455,198
| -11% | -$18M |
|
|
TYC
37
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $144M | 0.85% |
+3,341,919
| New | +$130M |
|
38
PPG Industries
PPG
$24.6B
| $141M | 0.83% |
1,491,424
-12,184
| -0.8% | -$1.1M |
|
39
Halliburton
HAL
$26.9B
| $140M | 0.82% |
2,758,326
+71,227
| +3% | +$3.68M |
|
40
Meta Platforms (Facebook)
META
$1.42T
| $136M | 0.8% |
2,492,992
+254,854
| +11% | +$12.8M |
|
|
41
Caterpillar
CAT
$375B
| $133M | 0.78% |
+1,465,359
| New | +$125M |
|
|
VIAB
42
DELISTED
Viacom Inc. Class B
VIAB
| $129M | 0.76% |
1,480,973
-28,071
| -2% | -$2.32M |
|
|
ARTC
43
DELISTED
ARTHROCARE CORP
ARTC
| $128M | 0.75% |
3,175,487
+240,410
| +8% | +$8.91M |
|
|
WFM
44
DELISTED
Whole Foods Market Inc
WFM
| $125M | 0.74% |
2,169,266
-164,134
| -7% | -$9.73M |
|
45
CNX Resources
CNX
$5.3B
| $124M | 0.73% |
3,925,177
+803,863
| +26% | +$24.6M |
|
46
BorgWarner
BWA
$13.1B
| $121M | 0.72% |
2,467,991
+292,699
| +13% | +$13.6M |
|
47
Amgen
AMGN
$208B
| $119M | 0.7% |
1,044,358
-158,193
| -13% | -$18M |
|
48
State Street
STT
$50.6B
| $116M | 0.69% |
1,586,775
-29,975
| -2% | -$2.1M |
|
49
Mettler-Toledo International
MTD
$28.6B
| $110M | 0.65% |
454,309
-18,572
| -4% | -$4.54M |
|
50
JPMorgan Chase
JPM
$935B
| $110M | 0.64% |
1,872,789
-17,759
| -0.9% | -$973K |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Westfield Capital Management held 389 positions worth $17B, up 8.6% from $15.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Westfield Capital Management's Q4 2013 filing shows 43 new, 82 increased, 143 reduced and 65 closed positions. Its largest new stake was Teva Pharmaceuticals: 5,174,039 shares worth $207M. The largest sale was VIROPHARMA INC, an estimated $188M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Westfield Capital Management's largest Q4 2013 buy was Teva Pharmaceuticals: 5,174,039 shares worth $207M.
- Westfield Capital Management added most to AbbVie in Q4 2013, an estimated $141M increase.
- Westfield Capital Management's biggest Q4 2013 reduction was VIROPHARMA INC, cutting an estimated $188M.
- Westfield Capital Management fully exited Citrix Systems Inc in Q4 2013, selling an estimated $131M.
- Westfield Capital Management's ten largest holdings make up 16% of its $17B portfolio in Q4 2013.
- Westfield Capital Management opened 43 new positions and closed 65 in Q4 2013.
- Westfield Capital Management's portfolio value rose 8.6% quarter-over-quarter to $17B.
Based on Westfield Capital Management's 13F filing for Q4 2013, filed 7 Feb 2014.